Cross-Reactivity Antibody Response after Vaccination with Modified Live and Killed Bovine Viral Diarrhoea Virus (BVD) Vaccines.
bovine viral diarrhoea virus
subgenotypes
vaccines
virus neutralisation test
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
11 Jul 2020
11 Jul 2020
Historique:
received:
04
06
2020
revised:
03
07
2020
accepted:
07
07
2020
entrez:
16
7
2020
pubmed:
16
7
2020
medline:
16
7
2020
Statut:
epublish
Résumé
Pestivirus A or bovine viral diarrhoea virus (BVDV) type 1 is responsible for cosmopolitan diseases affecting cattle and other ruminants, presenting a wide range of clinical manifestations, with relevant impact on zootechnic production. The objective of the present study was to verify whether animals immunised with four commercial vaccines also developed a protective humoral immunity against other viral subgenotypes than those contained in each vaccine. Four groups of 25 bovines each were formed and vaccinated according to the manufacturer's instructions of the commercial vaccines. On sera collected 28 days after the last vaccination, virus neutralisation tests (VNT) were performed using homologous and heterologous viruses and enzyme-linked immunosorbent assay (ELISA) methods. Finally, the VNT results were comparatively evaluated through a statistical analysis. Serological results highlighted that, although with a different degree of efficiency, the four vaccines resulted in not developing a solid antibody-mediated cross-immunity against all the strains used.
Identifiants
pubmed: 32664468
pii: vaccines8030374
doi: 10.3390/vaccines8030374
pmc: PMC7565157
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Virology. 2003 Jun 20;311(1):96-104
pubmed: 12832207
J Gen Virol. 2017 Aug;98(8):2106-2112
pubmed: 28786787
Vet Microbiol. 2003 Nov 7;96(4):327-36
pubmed: 14599780
Vet Microbiol. 2000 Nov 15;77(1-2):145-55
pubmed: 11042408
Biomed Res Int. 2014;2014:147145
pubmed: 25045658
Vet Microbiol. 2007 Nov 15;125(1-2):11-21
pubmed: 17582710
Vet J. 2011 Mar;187(3):330-4
pubmed: 20074985
Vet J. 2002 Jan;163(1):61-7
pubmed: 11749137
Comp Immunol Microbiol Infect Dis. 2011 Jan;34(1):35-9
pubmed: 19931181
Vet Microbiol. 2000 Nov 15;77(1-2):195-208
pubmed: 11042413
Am J Vet Res. 2007 Dec;68(12):1417-22
pubmed: 18052749
Vaccine. 2007 Aug 10;25(32):6140-5
pubmed: 17336433
Vet Microbiol. 2008 Sep 18;131(1-2):93-102
pubmed: 18424020
Biologicals. 2003 Jun;31(2):89-95
pubmed: 12770537
Vet Microbiol. 2015 Jan 30;175(1):1-6
pubmed: 25487441
Anim Health Res Rev. 2005 Jun;6(1):63-74
pubmed: 16164009
Vet Rec. 2003 Jun 28;152(26):795-800
pubmed: 12862167
Can J Vet Res. 2005 Jul;69(3):161-9
pubmed: 16187545
Vet Clin North Am Food Anim Pract. 2010 Mar;26(1):105-21, table of contents
pubmed: 20117546
J Clin Microbiol. 2014 Aug;52(8):2946-54
pubmed: 24899039
Am J Vet Res. 2003 Jan;64(1):65-9
pubmed: 12518880
Infect Genet Evol. 2012 Mar;12(2):324-31
pubmed: 22210133
J Virol. 2014 Jun;88(12):6983-92
pubmed: 24719408
Vet Microbiol. 2002 Nov 6;89(4):255-65
pubmed: 12383635
Am J Vet Res. 1995 Jun;56(6):755-9
pubmed: 7653884
J Am Vet Med Assoc. 2001 Oct 1;219(7):968-75
pubmed: 11601795
J Vet Diagn Invest. 1995 Jul;7(3):321-6
pubmed: 7578445
Viruses. 2017 May 26;9(6):
pubmed: 28587150
Prev Vet Med. 2005 Nov 15;72(1-2):17-30; discussion 215-9
pubmed: 16183156